Bienvenue aux Nations Unies
66th session (13- 17 March 2023), Vienna.
Report of the Commission on Narcotic Drugs on its sixty-sixth session [E/2023/28]
Resolutions/decisions adopted by the Council at the 2023 Management Segment as recommended by the Commission on its 66th session [E/2023/28, chap. I, sect. A; and E/2023/SR.25] 
19(d) 
7 June 2023
Decision 2023/318: Report of the Commission on Narcotic Drugs on its sixty-sixth session and provisional agenda for its sixty-seventh session
Decision 2023/319: Report of the International Narcotics Control Board
Further resolutions/decisions adopted by CND on its 66th session [E/2023/28, chap. I, sect. B]:
Resolution 66/1: Preparations for the midterm review to be held during the sixty-seventh session of the Commission on Narcotic Drugs, in 2024
Resolution 66/2: Safe handling and disposal of synthetic drugs, their precursors and other chemicals used in the illicit manufacture of drugs
Resolution 66/3: Strengthening information-sharing to increase scientific evidence-based support for international scheduling and the effective implementation of international scheduling decisions
Resolution 66/4: Promoting alternative development as a development-oriented drug control strategy that is sustainable and inclusive
Decision 66/1: Inclusion of 2-methyl-AP-237 in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 66/2: Inclusion of etazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 66/3: Inclusion of etonitazepyne in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 66/4: Inclusion of protonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 66/5: Inclusion of ADB-BUTINACA in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 66/6: Inclusion of alpha-PiHP in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 66/7: Inclusion of 3-methylmethcathinone in Schedule II of the Convention on Psychotropic Substances of 1971
Reconvened 65th session (8 - 9 December 2022), Vienna.
Report of the Commission on Narcotic Drugs on its reconvened sixty-fifth session [E/2022/28/Add.1]
Resolutions/decisions adopted by the Council at the 2023 Management Segment as recommended by the Commission on its reconvened 65th session [E/2022/28/Add.1, chap. I, sect. A; and E/2023/SR.43] 
19(d) 
25 July 2023
Decision 2023/332: Report of the Commission on Narcotic Drugs on its reconvened sixty-fifth session
Further resolutions/decisions adopted by CND on its reconvened 65th session [E/2022/28/Add.1, chap. I, sect. B]:
Resolution 65/5: Implementation of the budget for the biennium 2022–2023 for the Fund of the United Nations International Drug Control Programme
Further resources: